TACROLIMUS EXTENDED RELEASE CAPSULES

undefined/100 · Low Risk

Manufactured by Astellas Pharma US, Inc.

181,869 FDA adverse event reports analyzed

Top Adverse Reactions

OFF LABEL USE11,734 reports
DRUG INEFFECTIVE8,329 reports
PRODUCT USE IN UNAPPROVED INDICATION5,813 reports
DRUG INTERACTION5,363 reports
ACUTE KIDNEY INJURY5,057 reports
DIARRHOEA4,324 reports
TRANSPLANT REJECTION3,983 reports
CYTOMEGALOVIRUS INFECTION3,844 reports
PYREXIA3,690 reports
COVID 193,632 reports
TOXICITY TO VARIOUS AGENTS3,493 reports
PNEUMONIA3,351 reports
DEATH3,291 reports
RENAL IMPAIRMENT2,734 reports
SEPSIS2,712 reports
Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.